5 Best U.S. Stocks to Buy Now Under $10
Gray Television, Inc. (NYSE:GTN) is a company that operates television stations and digital platforms in the U.S. It owns or has affiliations with over 200 stations across 94 markets.
Pacific Biosciences Of California Inc. (PACB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 26,634,620 | $354,240,443 | -5% | 2.34% |
| 2. | Farallon Capital Thomas Steyer | 8,338,120 | $110,896,996 | +32% | 0.61% |
| 3. | Point72 Asset Management Steve Cohen | 6,661,633 | $88,599,719 | -9% | 0.26% |
| 4. | Avidity Partners Management David Witzke And Michael Gregory | 4,337,400 | $57,687,420 | +14% | 2.01% |
| 5. | Citadel Investment Group Ken Griffin | 3,921,303 | $52,153,330 | -23% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.01 | 1 | Officer | 215,156 | 2018-09-01 | Filing | |
| $2.01 | 5,989 | Officer | 215,155 | 2018-03-01 | Filing | |
| $4.07 | 3,244 | Officer | 194,166 | 2017-09-01 | Filing | |
| $4.07 | 3,212 | Officer | 190,922 | 2017-03-01 | Filing | |
| $4.07 | 3,147 | Officer | 187,710 | 2016-09-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.44 | 19,257 | Officer | 306,085 | 2023-09-29 | Filing | |
| $10.12 | 96,844 | Officer | 1,106,095 | 2023-09-18 | Filing | |
| $10.45 | 10,000 | Officer | 1,202,939 | 2023-09-11 | Filing | |
| $10.50 | 10,000 | Officer | 1,212,939 | 2023-08-17 | Filing | |
| $10.60 | 25,936 | Officer | 444,666 | 2023-08-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 66 | $551 | 0% | |
| 2. | 9 | $75 | 0% |
News See All
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q2 2023 Earnings Call Transcript
Operator: Hello and welcome to the PacBio Second Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
10 DNA Stocks Billionaires Are Loading Up On
Genomics is the study of a complete set of DNA within an organism.
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2023 Earnings Call Transcript
Operator: Good day and welcome to the PacBio First Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
12 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 12 gene editing stocks with the best long-term potential.
Top 10 CRISPR Stocks To Buy
Molecular biology, genetics, and genomics are in a significant period in history where technical capabilities and methods enable the editing of specific DNA segments and base pairs in living organisms...
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2022 Earnings Call Transcript
Operator: Hello, and welcome to the PacBio Fourth Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode.
Should You Add Pacific Biosciences of California (PACB) to Your Portfolio?
Jackson Square Partners, an investment management firm, released its “SMID-Cap Growth” Q3 2022 investor letter. A copy of the same can be downloaded here.
10 Best Medical Stocks Under $20
The healthcare industry has undergone a significant restructuring in the wake of the COVID-19 pandemic. There were multiple new healthcare trends in 2022 that have a lasting impact on the industry.
13 Best Genomics Stocks To Buy Now
Before talking about the best genomics stocks, it is important to understand what the term actually means.
Billionaire Hedge Funds
